Measuring comorbidity in older cancer patients

European Journal of Cancer

Volumn 36, Issue 4, 2000, Pages 453-471

  Extermann, M ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Aged; Aged > 80; Cancer; Charlson; CIRS; Comorbidity; ICED; Kaplan Feinstein

Indexed keywords

ANALYTIC METHOD; CANCER PATIENT; CANCER RESEARCH; COMORBIDITY; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; RATING SCALE; RELIABILITY; REVIEW; SENESCENCE;

AGED; AGED, 80 AND OVER; COMORBIDITY; HEALTH STATUS; HUMANS; MIDDLE AGED; NEOPLASMS; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 0034010518     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00319-6     Document Type: Review

References (50)

1. Yancik R., Ries L.A. Cancer in older persons. Cancer. 74:1994;1995-2003.
2. Fried L.P., Bandeen-Roche K., Kasper J.D., Guralnik J.M. Association of comorbidity with disability in older women: the Women's Health and Aging Study. J. Clin. Epidemiol. 52:1999;27-37.
3. Extermann M. Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol 2000, in press.
4. Monfardini S., Sorio R., Hoctin Boes G., Kaye S., Serraino D. Entry and evaluation of elderly patients in European Organization for Research and Treatment of Cancer (EORTC) new-drug-development studies. Cancer. 76:1995;333-338.
5. Trimble E.L., Carter C.L., Cain D., Freidlinn B., Undergleider R.S., Friedman M.A. Representation of older patients in cancer treatment trials. Cancer. 74:1994;2208-2214.
6. Extermann M., Overcash J., Lyman G.H., Parr J., Balducci L. Comorbidity and functional status are independent in older cancer patients. J. Clin. Oncol. 16:1998;1582-1587.
7. Newschaffer C.J., Bush T.L., Penberthy L.T. Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data. J. Clin. Epidemiol. 50:1997;725-733.
8. Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J. Clin. Epidemiol. 45:1992;613-619.
9. Romano P.S., Roos L.L., Jollis J.G. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data. differing perspectives J. Clin. Epidemiol. 46:1993;1075-1090.
10. Kiezsak S.M., Flanders W.D., Kosinski A.S., Shipp C.C., Karp H. A comparison of the Charlson Comorbidity Index derived from medical record data and administrative billing data. J. Clin. Epidemiol. 52:1999;137-142.
11. Yancik R., Wesley M.N., Ries L.A.G.et al. Comorbidity and age as predictors of risk for early mortality in male and female colon carcinoma patients. Cancer. 82:1998;2123-2134.
12. Charlson M.E., Pompei P., Ales K., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies. development and validation J. Chron. Dis. 40:1987;373-383.
13. Charlson M.E., Sax F.L., McKenzie C.R., Fields S.D., Braham R.L., Douglas R.G. Assessing illness severity. does clinical judgement work? J. Chron. Dis. 39:1986;439-452.
14. Inouye S.K., Peduzzi P.N., Robison J.T., Hughes J.S., Horwitz R.I., Concato J. Importance of functional measures in predicting mortality among older hospitalized patients. J. Am. Med. Assoc. 279:1998;1187-1193.
15. Chen H, Overcash J, Extermann M, Cantor A, Balducci L. Comprehensive geriatric assessment in elderly cancer patients: impact on overall survival and progression-free survival. Poster P76. Am Geriatric Soc Meeting. Philadelphia, PA, 19-23 May 1999.
16. Rochon P.A., Katz J.N., Morrow L.A.et al. Comorbid illness is associated with survival and length of hospital stay in patients with chronic disability. Med. Care. 34:1996;1093-1101.
17. Katz J.N., Chang L.C., Sangha O., Fossel A.H., Bates D.W. Can comorbidity be measured by questionnaire rather than medical record review? Med. Care. 34:1996;73-84.
18. Liu M., Domen K., Chino N. Comorbidity measures for stroke outcome research. a preliminary study Arch. Phys. Med. Rehabil. 78:1997;166-172.
19. Charlson M., Szatrowski T.P., Peterson J., Gold J. Validation of a comorbidity index. J. Clin. Epidemiol. 47:1994;1245-1251.
20. Chin M.H., Goldman L. Gender differences in 1-year survival and quality of life among patients admitted with congestive heart failure. Med. Care. 36:1998;1033-1046.
21. Knight E.L., Kiely D.K., Fish L.C., Marcantonio E.R., Minaker K.L. Atrial natriuretic peptide level contributes to a model of future mortality in the oldest old. J. Am. Geriatr. Soc. 46:1998;453-457.
22. Covinsky K.E., Kahana E., Chin M.H., Palmer R.M., Fortinsky R.H., Landefeld C.S. Depressive symptoms and 3-year mortality in older hospitalized medical patients. Ann. Intern. Med. 130:1999;563-569.
23. Skiest D.J., Rubinstein E., Carley N., Gioiella L., Lyons R. The importance of comorbidity in HIV-infected patients over 55. a retrospective case-control study Am. J. Med. 101:1996;605-611.
24. D'Hoore W., Sicotte C., Tilquin C. Risk adjustment in outcome assessment. the Charlson comorbidity index Methods Inf. Med. 32:1993;382-387.
25. Linn B.S., Linn M.W., Gurel L. Cumulative Illness Rating scale. J. Am. Geriatr. Soc. 16:1968;622-626.
26. Common Toxicity Criteria Version 2.0, National Institutes of Health, National Cancer Institute, April 1999. http://ctep.info.nih.gov/ctc3/default.htm.
27. Miller MD, Towers A. A manual of guidelines for scoring the cumulative illness rating scale for geriatrics (CIRS-G). University of Pittsburgh, May 1991.
28. Miller M.D., Paradis C.F., Houck P.R.et al. Rating chronic medical illness burden in geropsychiatric practice and research. application of the Cumulative Illness Rating Scale Psychiatry Res. 41:1992;237-248.
29. Parmelee P.A., Katz I.R., Lawton M.P. The relation of pain to depression among institutionalized aged. J. Gerontol. 46:1991;P15-P21.
30. Parmelee P.A., Thuras P.D., Katz I.R., Lawton M.P. Validation of the Cumulative Illness Rating Scale in a geriatric residential population. J. Am. Geriatr. Soc. 43:1995;130-137.
31. Keller B.K., Potter J.F. Predictors of mortality in outpatient geriatric evaluation and management clinic patients. J. Gerontol. 49:1994;M246-M251.
32. Di Iorio A., Longo A.L., Miltidieri Costanza A.et al. Characteristics of geriatric patients related to early and late readmission to hospital. Aging (Milano). 10:1998;339-346.
33. Conwell Y., Forbes N.T., Cox C., Caine E.D. Validation of a measure of physical illness burden at autopsy. the Cumulative Illness Rating Scale J. Am. Geriatr. Soc. 41:1993;38-41.
34. Greenfield S., Blanco D.M., Elashoff R.M., Ganz P. Patterns of care related to age of breast cancer patients. J. Am. Med. Assoc. 257:1987;2766-2770.
35. Imamura K., McKinnon M., Middleton R., Black N. Reliability of a comorbidity measure. the Index of Coexistent Disease (ICED) J. Clin. Epidemiol. 50:1997;1011-1016.
36. Bennett C.L., Greenfield S., Aronow H., Ganz P., Vogelzang N.J., Elashoff R.M. Patterns of care related to age of men with prostate cancer. Cancer. 67:1991;2633-2641.
37. Guadagnoli E., Shapiro C., Gurwitz J.H.et al. Age-related patterns of care. evidence against ageism in the treatment of early-stage breast cancer J. Clin. Oncol. 15:1997;2338-2344.
38. Greenfield S., Apolone G., McNeil B.J., Cleary P.D. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Med. Care. 31:1993;141-154.
39. Albertsen P.C., Fryback D.G., Storer B.E., Kolon T.F., Fine J. Long-term survival among men with conservatively treated localized prostate cancer. J. Am. Med. Assoc. 274:1995;626-631.
40. Krousel-Wood M.A., Abdoh A., Re R. Comparing comorbid-illness indices assessing outcome variation. the case of prostatectomy J. Gen. Intern. Med. 11:1996;32-38.
41. Waite K., Oddone E., Weinberger M.et al. Lack of association between patient's measured burden of disease and risk for hospital readmission. J. Clin. Epidemiol. 47:1994;1229-1236.
42. Greenfield S, Apolone G. Assessment of Comorbidity: the Index of Coexistent Disease (ICED). (Rating manual) New England Medical Center, Boston, MA, 1991.
43. Kaplan M.H., Feinstein A.R. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J. Chron. Dis. 27:1974;387-404.
44. Clemens J.D., Feinstein A.R., Holabird N., Cartwright S. A new clinical-anatomic staging system for evaluating prognosis and treatment of prostatic cancer. J. Chron. Dis. 39:1986;913-928.
45. Pompei P., Charlson M.E., Ales K., McKenzie C.R., Norton M. Relating patient characteristics at the time of admission to outcomes of hospitalization. J. Clin. Epidemiol. 10:1991;1063-1069.
46. Piccirillo J.F. Inclusion of comorbidity in a staging system for head and neck cancer. Oncology. 9:1995;831-836.
47. Silliman R.A., Lash T.L. Comparison of interview-based and medical-record based indices of comorbidity among breast cancer patients. Med. Care. 37:1999;339-349.
48. Newschaffer C.J., Bush T.L., Penberthy L.E., Bellantoni M., Helzlsour K., Diener-West M. Does comorbid disease interact with cancer? An epidemiologic analysis of mortality in a cohort of elderly breast cancer patients. J. Gerontol. 53:1998;M372-378.
49. Zincke H., Bergstrahl E.J., Blute M.L.et al. Radical prostatectomy for clinically localized prostate cancer. long-term results of 1,143 patients from a single institution J. Clin. Oncol. 12:1994;2254-2263.
50. Satariano W.A., Ragland D.R. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann. Intern. Med. 120:1994;104-110.